Abstract:Alexander Xiao, Christopher Warren, Waheeda Samady, Lucy Bilaver Northwestern University Feinberg School of Medicine, Center for Food Allergy and Asthma Research, Chicago, IL, USA Correspondence: Alexander Xiao Email There is a growing body of evidence that atopic skin disease may be due to disturbed microbial composition on the skin. 1 This dysbiosis has been observed in infants with eczema, with certain bacteria such as the Staphylococcal species playing an important role in the process. 2–4 In recent years, treatments for these conditions by altering the skin microbiome have been attempted with some success. One study found that intervention with topically applied R. mucosa was associated with decreased disease severity and S. aureus burden. 5 However, treatment with emollients, probiotic supplementation or "natural" remedies like tea tree oils have had limited evidence of efficacy. 1 Given this role the microbiome plays in atopic disease, our team has developed a novel, topical ointment primarily consisting of probiotics, honey, turmeric and B12 aimed at restoring a healthy skin microbiome. To examine its efficacy, we have completed the preliminary phases of a clinical trial. Our study was conducted as an Investigational New Drug with the FDA with approval from our Institutional IRB. Inclusion criteria were adults 18 and older with dry scalp and dandruff symptoms as determined by a trained research physician. Patients diagnosed with other scalp diseases such as psoriasis, tinea capitis, and pediculosis capitis, used systemic steroid or oral antibiotics in the past two months or had an allergy to any of the preparation components were excluded. Thirty-five adults (55% female, 40% White, 50% Asian, 5% Black, 5% Multiracial) with dry scalp were recruited and followed for this 2-week study. Participant median age was 26; IQR=8 years, range=20–78. The initial study visit consisted of a scalp exam and scalp photographs by a trained research physician to confirm that each participant had a dry scalp condition. At this time participants completed an intake survey including assessment of the participant demographics as well as the standardized assessments of scalp condition history and current symptoms described below. The scalp exam, photographs and intake survey provided the basis for our initial evaluation of disease and symptom severity through the Investigator Global Assessment (IGA), Total Severity Score (TSS) and Scalpdex. The IGA is a 5-point validated instrument that rates overall disease severity according to the following categories: 0 = clear, 1 = almost clear, 2 = mild disease, 3 = moderate disease, 4 = severe disease. The TSS represents the sum of erythema, scaling, and pruritus severity scores of the scalp disease. A minimum TSS score is 0 (none) and the maximum TSS score is 9 (severe). Scalpdex is a validated 23-item quality-of-life questionnaire that is completed by participants to measure their subjective improvement with treatment. Participants were instructed to liberally apply the topical preparation to their scalp once daily for 14 days, leave in place for at least 7 minutes, and rinse in the shower. Participants returned after 14 days of treatment for an in-person follow up including a physician scalp assessment, end photograph and exit survey. At that point, the IGA, TSS and Scalpdex were again determined. Results from paired t -tests with one-sided p-values found that after 2 weeks of treatment, overall disease severity by IGA decreased from 2.1 at baseline to 1.1 at the end of the trial (t(34 df )=8.15; p<0.001). Additionally, mean TSS scores fell from 3.5 at baseline to 1.8 at the conclusion (t(34 df )= p<0.001). Overall Scalpdex decreased from 46.0 to 39.5 (t(33 df )=3.4; p=0.001, reflecting significant reductions in the subjective quality of life burden associated with the scalp condition ( Table 1 ). Notably, significant decreases were observed for all three TSS subscales (p erythema <0.001; p scaling <0.001; p pruritis <0.001) as well as all three Scalpdex subscales (p symptoms =0.001; p emotion <0.001; p functioning =0.04) ( Tables 1 and 2 ). Additionally, the intervention was well-tolerated, without adverse effects or complaints reported by any study participants. Table 1 IGA, TSS and Scalpdex Scores Before and After Intervention Table 2 Scalpdex Score Subscales Before and After Intervention Overall, our preliminary data found that use of a novel, topical dry scalp product clinically reduced the symptoms and disease severity of dry scalp -Abstract Truncated-

Development of a new classification and scoring system for scalp conditions: Scalp Photographic Index (SPI)

Artificial intelligence-based prescription of personalized scalp cosmetics improved the scalp condition: efficacy results from 100 participants

Artificial intelligence (AI) based system for the diagnosis and classification of scalp health: AI-ScalpGrader

Evaluation of factors triggering sensitive scalp in Korean adult women

Development and Validation of a Composite Skin Quality Scale

A comparative study of an advanced skin imaging system in diagnosing facial pigmentary and inflammatory conditions

Establishment of clinical evaluation criteria for scalp seborrheic dermatitis

Methodology Validation: Correlating Adherent Scalp Flaking Score (ASFS) With Phototrichogram for Scalp Dandruff Evaluation in Adult Subjects

A Reevaluation of the Simplified Psoriasis Index (SPI) Using the Thai Language Version: A Study Examining the Validity, Reliability, and Interpretability of SPI When Used in Translation

The development and validation of an acne self-regulation inventory

A Pilot Study to Assess the Reliability of Digital Image-Based PASI Scores Across Patient Skin Tones and Provider Training Levels.

Novel Topical Treatment for Dandruff & Dry Scalp Through Sustained Balance in Skin Microbiome

Development and Validation of a Novel Holistic Skin Quality Assessment Scale

In‐person validation of the Ichthyosis Scoring System

Scalp Psoriasis in China: a Survey on Epidemiological Characteristics and Influencing Factors

Assessment of features in facial hyperpigmentation: Comparison study between VISIA and CSKIN

Evaluation of the severity and triggering factors of sensitive scalp in Chinese females

Development and validation of a global photonumeric scale for evaluating skin quality of aged female facial skin

From consistent subjective assessment of skin sensitivity severity to its accurate objective scoring

Assessing therapeutic effectiveness of scalp treatments for dandruff and seborrheic dermatitis, part 1: a reliable and relevant method based on the adherent scalp flaking score (ASFS)

The continuous development of a complete and objective automatic grading system of facial signs from selfie pictures: Asian validation study and application to women of three ethnic origins, differently aged